Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Involvement of leukotriene B4 in arthritis models
1998
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
In vitro selection, characterization, and application of deoxyribozymes that cleave RNA
2005
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Cytogenetics in acute leukemia
2003
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Highly enantioselective DNA-based catalysis
2006 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
tetra-O-Methylnordihydroguaiaretic acid inhibits melanoma in vivo
2001
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
1994
Drug-Induced Hepatotoxicity
2003 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Inhibitory Effects of Inhibitors of Arachidonic Acid Metabolism on the Evolution of Rat Liver Preneoplastic Foci into Nodules and Hepatocellular Carcinomas with or without Phenobarbital Exposure
1993
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
2002
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
2004
Approaches for the sequence-specific knockdown of mRNA
2003
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Inflammatory Bowel Disease
2002 Standout
Graft-versus-host disease
2009 Standout
DNA‐Based Asymmetric Catalysis
2005 StandoutNobel
Circos: An information aesthetic for comparative genomics
2009 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
1999
Bone Marrow Transplantation
1994
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Characterization of a DNA-Cleaving deoxyribozyme
2001
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
2007
Revealing the world of RNA interference
2004 StandoutNatureNobel
A review of autologous hematopoietic cell transplantation
2000 Nobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Preferential Activation of the 8–17 Deoxyribozyme by Ca Ions
2000
Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support
2004
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
The thalidomide saga
2007
Specific Killing of Ph+Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered Anti-bcr/ablSmall Hairpin RNA
2003
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Impact of Nanotechnology on Drug Delivery
2009 Standout
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Functional Nucleic Acid Sensors
2009 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA
2004 StandoutNobel
Making Catalytic DNAs
2000 Science
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).
1995
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?
1994
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study
2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
DNAzyme-based biosensors and nanodevices
2014
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Nucleic-acid therapeutics: basic principles and recent applications
2002
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
1991
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Directed Evolution of Nucleic Acid Enzymes
2004
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Hodgkin's lymphoma
2003
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cytokine-induced radiation protection and sensitization
1996
Works of DS Snyder being referenced
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
1994
Inhibition of bcr-abl Oncogene Expression by Novel Deoxyribozymes (DNAzymes)
1999
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
1999
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
2000
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789]
1987
Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines.
1989
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course
1994
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]
1992
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Lipoxygenase metabolites of arachidonic acid modulate hematopoiesis
1986
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
1995
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission
1993
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase
1994
Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line
1993
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995